全文获取类型
收费全文 | 20297篇 |
免费 | 2523篇 |
国内免费 | 189篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 305篇 |
妇产科学 | 267篇 |
基础医学 | 995篇 |
口腔科学 | 523篇 |
临床医学 | 5817篇 |
内科学 | 1396篇 |
皮肤病学 | 115篇 |
神经病学 | 649篇 |
特种医学 | 295篇 |
外科学 | 2377篇 |
综合类 | 2510篇 |
预防医学 | 4045篇 |
眼科学 | 106篇 |
药学 | 2540篇 |
133篇 | |
中国医学 | 482篇 |
肿瘤学 | 391篇 |
出版年
2024年 | 31篇 |
2023年 | 451篇 |
2022年 | 564篇 |
2021年 | 1143篇 |
2020年 | 1198篇 |
2019年 | 1230篇 |
2018年 | 1124篇 |
2017年 | 1010篇 |
2016年 | 1040篇 |
2015年 | 916篇 |
2014年 | 1514篇 |
2013年 | 1992篇 |
2012年 | 1144篇 |
2011年 | 1224篇 |
2010年 | 963篇 |
2009年 | 1000篇 |
2008年 | 968篇 |
2007年 | 947篇 |
2006年 | 751篇 |
2005年 | 644篇 |
2004年 | 500篇 |
2003年 | 376篇 |
2002年 | 313篇 |
2001年 | 287篇 |
2000年 | 286篇 |
1999年 | 214篇 |
1998年 | 188篇 |
1997年 | 160篇 |
1996年 | 110篇 |
1995年 | 82篇 |
1994年 | 54篇 |
1993年 | 51篇 |
1992年 | 60篇 |
1991年 | 32篇 |
1990年 | 35篇 |
1989年 | 22篇 |
1988年 | 27篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 41篇 |
1984年 | 100篇 |
1983年 | 29篇 |
1982年 | 31篇 |
1981年 | 38篇 |
1980年 | 25篇 |
1979年 | 10篇 |
1978年 | 17篇 |
1977年 | 15篇 |
1976年 | 8篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
991.
抗肿瘤药物配制后稳定性探讨 总被引:2,自引:0,他引:2
检索中英文数据库,查阅有关文献,综述临床常用静脉用抗肿瘤药物配制后稳定的条件及时间,为临床安全用药提供参考。 相似文献
992.
993.
994.
995.
996.
《Research in social & administrative pharmacy》2014,10(2):387-397
BackgroundGiven the demanding nature of providing pharmacy services, coupled with the expanded scope of practice of the professions in jurisdictions around the world, greater commitment to continuous quality improvement through adoption of quality-related event (QRE) reporting is necessary to ensure patient safety. Pharmacy regulatory authorities (PRAs) are in a unique position to enhance QRE reporting and learning through the standardization of expected practice.ObjectiveThis study was aimed to gain a better understanding of the perceived roles of PRAs in enhancing QRE reporting and learning in community pharmacies, and identifying regulatory best practices to execute such roles.MethodsA purposive case sampling approach was used to identify PRA staff members from two groups (Deputy registrars and pharmacy inspectors) in 10 Canadian jurisdictions to participate in focus groups in the fall of 2011. Focus groups were used to explore perceptions of the role of PRAs in enhancing and promoting QRE reporting and learning, and perceived barriers to effective implementation in practice. Thematic analysis was used to analyze the qualitative data.ResultsTwo focus groups were conducted, one with seven Deputy registrars/Practice managers, and one with nine pharmacy inspectors. Five themes were identified, including (1) defining QRE reporting and compliance, (2) navigating role conflict, (3) educating for enhanced QRE reporting and learning, (4) promoting the positive/removing the fear of QREs, and (5) tailoring QRE reporting and learning consistency.ConclusionsOverall, participants perceived a strong role for PRAs in enhancing QRE reporting and learning and providing education for pharmacies to support their compliance with reporting standards. However, PRAs must navigate the conflict inherent in both educating and promoting a process for achieving a standard while simultaneously inspecting compliance to that standard. Ensuring pharmacies have autonomy in operationalizing standards may help to mitigate this conflict. Finally, greater education for PRAs themselves to better inspect compliance and in order to better communicate the benefits of QRE reporting and learning to pharmacies would be beneficial. 相似文献
997.
998.
《Research in social & administrative pharmacy》2014,10(4):623-632
BackgroundMedication-related problems (MRPs) are a concern in primary care settings. Pharmacists based in the community or community pharmacies are able to identify, resolve and prevent MRPs; however, the lack of a formal partnership with physicians and poor access to patients' medical records are limitations. In Australia, delivery of pharmacist services within general practice clinics is rare.ObjectivesTo evaluate the effectiveness of consultations by pharmacists based within primary care medical practices.MethodsA prospective, before-after intervention study was conducted at two primary health care (general practice) clinics in Melbourne, Australia. Participants were clinic patients who had risk-factors for MRPs (e.g. polypharmacy). Patients received a consultation with the pharmacist in a private consulting room at the clinic or in their home. The pharmacist reviewed the patient's medication regimen and adherence, with full access to their medical record, provided patient education, and produced a report for the general practitioner. The primary outcome was the number of MRPs identified by the pharmacist, and the number that remained unresolved 6 months after the pharmacist consultation. Secondary outcomes included medication adherence, health service use, and patient satisfaction.ResultsEighty-two patients were recruited and 62 (75.6%) completed the study. The median number of MRPs per patient identified by the practice pharmacist was 2 (interquartile range [IQR] 1, 4). Six months after review, this fell to 0 (IQR 0, 1), P < 0.001. The proportion of patients who were adherent to their medications improved significantly, according to both the Morisky (44.1% versus 62.7%, P = 0.023) and the Tool for Adherence Behaviour Screening (TABS) (35.6% versus 57.6%, P = 0.019) scales. There was no significant effect on health service use. Patients were highly satisfied with the pharmacist consultations.ConclusionsConsultations undertaken by pharmacists located within primary health care clinics were effective in identifying and resolving MRPs. The consultations were well received by patients and were associated with improvements in medication adherence. 相似文献
999.
通过对《临床用药须知》内涵的解读,联系临床药学的职责,探索如何在临床药学服务中更好地发挥《临床用药须知》的专业指导作用. 相似文献
1000.